1 / 38

Clinical Pharmacokinetics

Clinical Pharmacokinetics. Introduction. What is clinical pharmacokinetics ?. Study of the time course of a drug’s movement through the body. Understanding of what the body does to (or with) the drug. Application of Therapeutic Drug Monitoring (TDM) and individualisation of drug therapy.

arnon
Download Presentation

Clinical Pharmacokinetics

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Clinical Pharmacokinetics Introduction

  2. What is clinical pharmacokinetics ? • Study of the time course of a drug’s movement through the body. • Understanding of what the body does to (or with) the drug. • Application of Therapeutic Drug Monitoring (TDM) and individualisation of drug therapy.

  3. Outline • Review of Concepts • Clearance, K, Half-Life, Volume of Distribution • Therapeutic drug Monitoring • Pharmacokinetic Drug Interactions • Cases • Discussion/Questions

  4. Pharmacokinetics (PK) & pharmacodynamics (PD) • PK - What the body does to the drug? • Absorption; distribution, metabolism, excretion (ADME) • PD - What the drug does to the body? • Drug concentration at the site of action or in the plasma is related to a magnitude of effect

  5. Pharmacokinetics (PK) and pharmacodynamics (PD) Plasma Site Concen- of tration Action Dose Effects PK PD

  6. Pharmacokinetics vs Pharmacodynamics…concept • Fluoxetine increases plasma concentrations of amitriptyline. This is a pharmacokinetic drug interaction. • Fluoxetine inhibits the metabolism of amitriptyline and increases the plasmaconcentration of amitriptytline.

  7. Pharmacokinetics vs Pharmacodynamics…concept • If fluoxetine is given with tramadol serotonin syndrom can result. This is a pharmacodynamic drug interaction. • Fluoxetine and tramadol both increase availability of serotonin leading to the possibility of “serotonin overload” This happens without a change in the concentration of either drug.

  8. Basic Parameters • In the next few slides the basic concepts and paramaters will be described and explained. • In pharmacokinetics the body is represented as a single or multiple compartments in to which the drug is distributed. • Some of the parameters are therefore a little abstract as we know the body is much more complicated !

  9. Volume of Distribution, Clearance and Elimination Rate Constant V Volume 100 L Clearance 10 L/hr

  10. Volume of Distribution, Clearance and Elimination Rate Constant V Volume 100 L (Vi) V2 Cardiac and Skeletal Muscle Clearance 10 L/hr

  11. Volume 100 L (Vi) V2 Cardiac and Skeletal Muscle V Clearance 10 L/hr Volume of Distribution = Dose_______ Plasma Concentration

  12. Volume 100 L (Vi) V2 Cardiac and Skeletal Muscle V Clearance 10 L/hr Clearance = Volume of blood cleared of drug per unit time

  13. Volume 100 L (Vi) V2 Cardiac and Skeletal Muscle V Clearance 10 L/hr Clearance = 10 L/hr Volume of Distribution = 100 L What is the Elimination Rate Constant (k) ?

  14. CL = kV k = 10 Lhr -1 = 0.1 hr -1 100 L 10 % of the “Volume” is cleared (of drug) per hour k = Fraction of drug in the body removed per hour

  15. CL = kV If V increases then k must decrease as CL is constant

  16. Important Concepts • VD is a theoretical Volume and determines the loading dose • Clearance is a constant and determines the maintenance dose • CL = kVD • CL and VD are independent variables • k is a dependent variable

  17. Volume of Distribution Apparent volume of distribution is the theoretical volume that would have to be available for drug to disperse in if the concentration everywhere in the body were the same as that in the plasma or serum, the place where drug concentration sampling generally occurs.

  18. Volume of Distribution • An abstract concept • Gives information on HOW the drug is distributed in the body • Used to calculate a loading dose

  19. Loading Dose Dose = Cp(Target) x VD

  20. Question • What Is the is the loading dose required fro drug A if; • Target concentration is 10 mg/L • VD is 0.75 L/kg • Patients weight is 75 kg • Answer is on the next slide

  21. Answer: Loading Dose of Drug A • Dose = Target Concentration x VD • VD = 0.75 L/kg x 75 kg = 56.25 L • Target Conc. = 10 mg/L • Dose = 10 mg/L x 56.25 L • = 565 mg • This would probably be rounded to 560 or even 500 mg.

  22. Clearance • Ability of organs of elimination (e.g. kidney, liver to “clear” drug from the bloodstream • Volume of fluid which is completely cleared of drug per unit time • Units are in L/hr or L/hr/kg • Pharmacokinetic term used in determination of maintenance doses

  23. Maintenance DoseCalculation • Maintenance Dose = CL x CpSSav • CpSSav is the target average steady state drug concentration • The units of CL are in L/hr or L/hr/kg • Maintenance dose will be in mg/hr so for total daily dose will need multiplying by 24

  24. Question • What maintenance dose is required for drug A if; • Target average SS concentration is 10 mg/L • CL of drug A is 0.015 L/kg/hr • Patient weighs 75 kg • Answer on next slide.

  25. Answer • Maintenance Dose = CL x CpSSav • CL = 0.015 L/hr/kg x 75 = 1.125 L/hr • Dose = 1.125 L/hr x 10 mg/L = 11.25 mg/hr • So will need 11.25 x 24 mg per day= 270 mg

  26. Half-Life and k • Half-life is the time taken for the drug concentration to fall to half its original value • The elimination rate constant (k) is the fraction of drug in the body which is removed per unit time.

  27. Drug Concentration C1 Time Exponential decay dC/dt  C = -k.C C2

  28. Log Concn. Time Time to eliminate ~ 4 t1/2 C0 C0/2 t1/2 t1/2 t1/2

  29. Cp2 = Cp1.e-kt t1/2 = 0.693/k Integrating: Logarithmic transform: lnC2= lnC1 - kt logC2 = logC1 - kt/2.303 Elimination Half-Life: t1/2 = ln2/k

  30. Steady-State • Steady-state occurs after a drug has been given for approximately five elimination half-lives. • At steady-state the rate of drug administration equals the rate of elimination and plasma concentration - time curves found after each dose should be approximately superimposable.

  31. Accumulation to Steady State 100 mg given every half-life … 200 194 187.5 175 150 100 … 97 100 94 87.5 75 50

  32. What is Steady State (SS) ?Why is it important ? • Rate in = Rate Out • Reached in 4 – 5 half-lives (linear kinetics) • Important when interpreting drug concentrations in TDM or assessing clinical response

  33. Therapeutic Drug Monitoring Some Principles

  34. Therapeutic Index • Therapeutic index = toxic dose/effective dose • This is a measure of a drug’s safety • A large number = a wide margin of safety • A small number = a small margin of safety

  35. Drug Concentrations May BeUseful When There Is: • An established relationship between concentration and response or toxicity • A sensitive and specific assay • An assay that is relatively easy to perform • A narrow therapeutic range • A need to enhance response/preventtoxicity

  36. Why Measure Drug Concentrations? • Lack of therapeutic response • Toxic effects evident • Potential for non-compliance • Variability in relationship of dose andconcentration • Therapeutic/toxic actions not easilyquantified by clinical endpoints

  37. Potential for Error When Using TDM • Assuming patient is at steady-state • Assuming patient is actually taking the drug as prescribed • Assuming patient is receiving drug as prescribed • Not knowing when the drug concentration was measured inrelation to dose administration • Assuming the patient is static and that changes in condition don’t affect clearance • Not considering drug interactions

More Related